[HTML][HTML] Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral …
M Wawruch, M Petrova, T Tesar, J Murin… - Frontiers in …, 2023 - frontiersin.org
Introduction: As in other chronic conditions, medication adherence is important in the
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial …
M Wawruch, M Petrova, T Tesar… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction: As in other chronic conditions, medication adherence is important in the
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
[HTML][HTML] Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral …
M Wawruch, M Petrova, T Tesar, J Murin… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Introduction: As in other chronic conditions, medication adherence is important in the
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial …
M Wawruch, M Petrova, T Tesar, J Murin… - Frontiers in …, 2023 - europepmc.org
Introduction: As in other chronic conditions, medication adherence is important in the
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial …
M Wawruch, M Petrova, T Tesar, J Murin… - Frontiers in …, 2023 - europepmc.org
Introduction: As in other chronic conditions, medication adherence is important in the
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …